Literature DB >> 16777603

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.

Xuewu Zhang1, Jodi Gureasko, Kui Shen, Philip A Cole, John Kuriyan.   

Abstract

The mechanism by which the epidermal growth factor receptor (EGFR) is activated upon dimerization has eluded definition. We find that the EGFR kinase domain can be activated by increasing its local concentration or by mutating a leucine (L834R) in the activation loop, the phosphorylation of which is not required for activation. This suggests that the kinase domain is intrinsically autoinhibited, and an intermolecular interaction promotes its activation. Using further mutational analysis and crystallography we demonstrate that the autoinhibited conformation of the EGFR kinase domain resembles that of Src and cyclin-dependent kinases (CDKs). EGFR activation results from the formation of an asymmetric dimer in which the C-terminal lobe of one kinase domain plays a role analogous to that of cyclin in activated CDK/cyclin complexes. The CDK/cyclin-like complex formed by two kinase domains thus explains the activation of EGFR-family receptors by homo- or heterodimerization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777603     DOI: 10.1016/j.cell.2006.05.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  628 in total

1.  Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.

Authors:  Robert Y C Yang; Katherine S Yang; Linda J Pike; Garland R Marshall
Journal:  Chem Biol Drug Des       Date:  2010-05-04       Impact factor: 2.817

2.  Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.

Authors:  Rebecca A Scheck; Melissa A Lowder; Jacob S Appelbaum; Alanna Schepartz
Journal:  ACS Chem Biol       Date:  2012-06-05       Impact factor: 5.100

3.  Structural basis for basal activity and autoactivation of abscisic acid (ABA) signaling SnRK2 kinases.

Authors:  Ley-Moy Ng; Fen-Fen Soon; X Edward Zhou; Graham M West; Amanda Kovach; Kelly M Suino-Powell; Michael J Chalmers; Jun Li; Eu-Leong Yong; Jian-Kang Zhu; Patrick R Griffin; Karsten Melcher; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 4.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

5.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

Review 6.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

7.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

8.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 9.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

10.  Computational delineation of tyrosyl-substrate recognition and catalytic landscapes by the epidermal growth factor receptor tyrosine kinase domain.

Authors:  Yingting Liu; Ravi Radhakrishnan
Journal:  Mol Biosyst       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.